Investment professional and operator with experience across private equity, venture capital and corporate development, often active in growth-stage healthcare and technology transactions. Ryan Robert Robaugh is known for sourcing deals, executing M&A and supporting portfolio growth through board and operating roles, with a focus on commercial strategy, capital raises and value‑creation initiatives for institutional investors.
Investment professional and operator with experience across private equity, venture capital and corporate development, often active in growth-stage healthcare and technology transactions. Ryan Robert Robaugh is known for sourcing deals, executing M&A and supporting portfolio growth through board and operating roles, with a focus on commercial strategy, capital raises and value‑creation initiatives for institutional investors.
Prefers growth-stage investments in healthcare and technology, combining private equity rigor with venture agility to underwrite scalable commercial models and durable margins. Emphasizes active deal sourcing, fast diligence on go‑to‑market traction and capital-efficient product-market fit, then drives value through board-level commercial strategy, capital raises and operational KPIs. Allocates capital with a bias to follow-on reserve, disciplined downside protection and three-to-seven year time horizons, prioritizing repeatable revenue growth and measurable cash-flow pathways.
Prefers growth-stage investments in healthcare and technology, combining private equity rigor with venture agility to underwrite scalable commercial models and durable margins. Emphasizes active deal sourcing, fast diligence on go‑to‑market traction and capital-efficient product-market fit, then drives value through board-level commercial strategy, capital raises and operational KPIs. Allocates capital with a bias to follow-on reserve, disciplined downside protection and three-to-seven year time horizons, prioritizing repeatable revenue growth and measurable cash-flow pathways.
| Trades 252 | Longs Won 162/252 64% | Profit Factor 14.46 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $357,205.44 |
| Average Win $172,476.92 | Best Trade (Jul 15) $2.87M | Sharpe Ratio -10.21 |
| Average Loss -$21,475.38 | Worst Trade (Jul 10) -$235,968.08 | Z-Score 5.61 (100%) |
| Commissions $0 | Avg. Trade Length 11m 1w 1d | Expectancy $103,208.24 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 6,536 | 5,882 | 5,229 | 4,575 | 3,922 | 3,268 | 2,614 | 1,961 | 1,307 | 654 |